scispace - formally typeset
Y

Yi Chen

Researcher at Chinese Academy of Sciences

Publications -  5695
Citations -  344243

Yi Chen is an academic researcher from Chinese Academy of Sciences. The author has contributed to research in topics: Large Hadron Collider & Medicine. The author has an hindex of 217, co-authored 4342 publications receiving 293080 citations. Previous affiliations of Yi Chen include Rochester Institute of Technology & National Institutes of Health.

Papers
More filters
Journal ArticleDOI

Synthesis of mesoscale ordered two-dimensional π-conjugated polymers with semiconducting properties

Gianluca Galeotti, +21 more
- 18 May 2020 - 
TL;DR: This work demonstrates the fabrication of mesoscale ordered two-dimensional π-conjugated polymer kagome lattices with semiconducting properties, Dirac cone structures and flat bands on Au(111) by combining a rigid azatriangulene precursor and a hot dosing approach, which favours molecular diffusion and eliminates voids in the network.
Journal ArticleDOI

Evidence for light-by-light scattering and searches for axion-like particles in ultraperipheral PbPb collisions at sNN=5.02TeV

Albert M. Sirunyan, +2325 more
- 10 Oct 2019 - 
TL;DR: In this article, the light-by-light scattering process in ultra-peripheral PbPb collisions at a centre-of-mass energy per nucleon pair of 5.02 TeV is reported.
Journal ArticleDOI

Calibration of the LIGO gravitational wave detectors in the fifth science run

J. Abadie, +554 more
- 01 Dec 2010 - 
TL;DR: In this paper, the authors describe the calibration of the instruments in the S5 data set, including measurement techniques and uncertainty estimation, for the LIGO data set of the fifth science run (S5).
Journal ArticleDOI

Multisystem Bayesian constraints on the transport coefficients of QCD matter

D. Everett, +47 more
- 01 May 2021 - 
TL;DR: Eden et al. as discussed by the authors studied the properties of the strongly coupled quark-gluon plasma with a multistage model of heavy-ion collisions that combines the TRENTo initial condition ansatz, free-streaming, viscous relativistic hydrodynamics, and a hadronic transport.
Journal ArticleDOI

VEGF as a marker for outcome among advanced breast cancer patients receiving anti-VEGF therapy with bevacizumab and vinorelbine chemotherapy.

Harold J. Burstein, +13 more
- 01 Dec 2008 - 
TL;DR: Plasma VEGF warrants further evaluation as a prognostic marker for treatment outcome in advanced breast cancer patients receiving anti-VEGF therapy and is well tolerated and effective as treatment for refractory breast cancer.